You are here

Our science / Clinical Trials / Find a Trial / NCT00163215

Growth Retardation In Children With Special Pathological Conditions Or Disease

Back to Search Print Save as PDF Bookmark Trial

NCT00163215

Last updated on March 15, 2019
Back to Search Print Save as PDF Bookmark Trial

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Annemasse Cedex, , 74107 France
See other locations
Contact
1-800-718-1021
[email protected]
Related Links
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Endocrine System Diseases
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
11-13 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Bone age

- Naive child: Measured Height

- Child currently treated by GH

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Idiopathic short stature

- Syndrome known to be associated with an increased risk of cancer e.g. family history
of adenomatous polyposis

NCT00163215
Pfizer
Completed
Growth Retardation In Children With Special Pathological Conditions Or Disease

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Advanced Search

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now